NEW YORK, Feb. 26, 2018 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") – a leading wealth manager and
investment bank and a subsidiary of Oppenheimer Holdings (NYSE:OPY) – today announced Leland
Gershell, M.D., Ph.D. joined the Firm as Managing Director and Senior Analyst on the Life Sciences research team. With
extensive experience in the field, he is responsible for expanding and distinguishing Oppenheimer's Life Sciences research
product.
Gershell joins from Capricor Therapeutics, which develops therapies for rare pediatric diseases, and previously served as CFO
of Tonix Pharmaceuticals, a company developing small-molecule drug candidates for neuropsychiatric disorders. His achievements
include raising over $140 million across a variety of equity financing mechanisms and securing
investment participation from leading Life Science institutions. Prior to his corporate roles, Leland covered a variety of
biotechnology and pharmaceutical companies as both a sell-side and buy-side analyst.
"This is a very dynamic time in the healthcare sector, with new therapies poised to revolutionize business models, as well as
the continued focus on technology innovation using artificial intelligence and big data," said John
Parks, Managing Director & Director of Equity Research at Oppenheimer. "Leland's experience, both financial and
corporate, will help guide the Life Sciences research team through this era of change and help expand Oppenheimer's research
offerings."
Healthcare and Life Sciences has historically been a strong focus for the Firm. Oppenheimer reaffirmed its commitment to
Healthcare Investment Banking last year with a series of new hires.
Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc. (Oppenheimer), a principal
subsidiary of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange), and its affiliates provide a full range of wealth
management, securities brokerage and investment banking services to high-net-worth individuals, families, corporate executives,
local governments, businesses and institutions.
View original content:http://www.prnewswire.com/news-releases/oppenheimer-strengthens-life-sciences-team-with-new-managing-director-300603628.html
SOURCE Oppenheimer & Co. Inc.